Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.

[1]  K. Marder,et al.  Frequency of LRRK2 mutations in early- and late-onset Parkinson disease , 2006, Neurology.

[2]  R. Myers,et al.  Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study , 2006, The Lancet Neurology.

[3]  Sonja W. Scholz,et al.  Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.

[4]  J. Nutt,et al.  LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. , 2006, American journal of human genetics.

[5]  M. Farrer,et al.  Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. , 2006, Archives of neurology.

[6]  A. Samii,et al.  Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease , 2006, Neurology.

[7]  M. Farrer,et al.  Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries , 2006, Movement disorders : official journal of the Movement Disorder Society.

[8]  D. Hernandez,et al.  Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[9]  R. Myers,et al.  Considerations for genomewide association studies in Parkinson disease. , 2006, American journal of human genetics.

[10]  Matthew J. Farrer,et al.  LRRK2 in Parkinson's disease: protein domains and functional insights , 2006, Trends in Neurosciences.

[11]  B. Oostra,et al.  A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan , 2006, Neurogenetics.

[12]  H. Inoko,et al.  Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. , 2006, Human molecular genetics.

[13]  M. Farrer.  Genetics of Parkinson disease: paradigm shifts and future prospects , 2006, Nature Reviews Genetics.

[14]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[15]  P. Pollak,et al.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.

[16]  T. Meitinger,et al.  Common variants of LRRK2 are not associated with sporadic Parkinson's disease , 2005, Annals of neurology.

[17]  Wing-Kin Sung,et al.  Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease. , 2005, Human molecular genetics.

[18]  Mariza de Andrade,et al.  High-resolution whole-genome association study of Parkinson disease. , 2005, American journal of human genetics.

[19]  M. Farrer,et al.  Lrrk2 pathogenic substitutions in Parkinson's disease , 2005, Neurogenetics.

[20]  P. S. St George-Hyslop,et al.  LRRK2 gene in Parkinson disease , 2005, Neurology.

[21]  M. Farrer,et al.  The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients , 2005, Neuroscience Letters.

[22]  Timothy Lynch,et al.  Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. , 2005, American journal of human genetics.

[23]  T. Meitinger,et al.  Multiple regions of α‐synuclein are associated with Parkinson's disease , 2005, Annals of neurology.

[24]  H. Hamm,et al.  Interaction of Gβγ with RACK1 and other WD40 repeat proteins , 2004 .

[25]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[26]  A. Wallgren,et al.  The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation , 2001, European Journal of Human Genetics.

[27]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[28]  D. Curtis,et al.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci , 1995, Annals of human genetics.

[29]  P. Kolatkar,et al.  The LRRK2 Gly2385Arg variant is associated with Parkinson’s disease: genetic and functional evidence , 2006, Human Genetics.

[30]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[31]  P. Sham.  Statistics in human genetics , 1997 .